Increases in MHCII(hi)/CD11c+ dendritic cells and activated MHC II+ microglia were also observed in tumor-rechallenged long-term survivors relative to saline-injected long-term survivors (Fig 4E and 4F). This evidence concerns the gene ITGAX and neoplasm.